Cargando…

Therapeutic responsiveness to vagus nerve stimulation in patients receiving beta-blockade for heart failure with reduced ejection fraction

BACKGROUND: The effect of beta-blockade (BB) on response to vagus nerve stimulation (VNS) has not been reported in patients with heart failure and reduced ejection fraction (HFrEF). In the ANTHEM-HF Study, 60 patients received chronic cervical VNS. Background pharmacological therapy remained unchang...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dede, Enea, Gregory, Douglas D., Ardell, Jeffrey L., Libbus, Imad, DiCarlo, Lorenzo A., Premchand, Rajendra K., Sharma, Kamal, Mittal, Sanjay, Monteiro, Rufino, Anand, Inder S., Düngen, Hans-Dirk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556756/ https://www.ncbi.nlm.nih.gov/pubmed/34754899 http://dx.doi.org/10.1016/j.ijcha.2021.100888

Ejemplares similares

Baseline NT-proBNP and responsiveness to autonomic regulation therapy in patients with heart failure and reduced ejection fraction
por: Anand, Inder, et al.
Publicado: (2020)

Persistent Autonomic Engagement and Cardiac Control After Four or More Years of Autonomic Regulation Therapy Using Vagus Nerve Stimulation
por: Libbus, Imad, et al.
Publicado: (2022)

Background pharmacological therapy in the ANTHEM‐HF: comparison to contemporary trials of novel heart failure therapies
por: Premchand, Rajendra K., et al.
Publicado: (2019)

Autonomic regulation therapy to enhance myocardial function in heart failure patients: the ANTHEM‐HFpEF study
por: DiCarlo, Lorenzo A., et al.
Publicado: (2017)

Multifactorial Benefits of Chronic Vagus Nerve Stimulation on Autonomic Function and Cardiac Electrical Stability in Heart Failure Patients With Reduced Ejection Fraction
por: Verrier, Richard L., et al.
Publicado: (2022)

Comparison of symptomatic and functional responses to vagus nerve stimulation in ANTHEM‐HF, INOVATE‐HF, and NECTAR‐HF
por: Anand, Inder S., et al.
Publicado: (2020)

Effect of defibrillation on the performance of an implantable vagus nerve stimulation system
por: Libbus, Imad, et al.
Publicado: (2021)

Chronic vagus nerve stimulation is associated with multi-year improvement in intrinsic heart rate recovery and left ventricular ejection fraction in ANTHEM-HF
por: Nearing, Bruce D., et al.
Publicado: (2021)

Implantable vagus nerve stimulation system performance is not affected by internal or external defibrillation shocks
por: Libbus, Imad, et al.
Publicado: (2021)

Stochastic vagus nerve stimulation affects acute heart rate dynamics in rats
por: Lee, Steven W., et al.
Publicado: (2018)

Chronic cyclic vagus nerve stimulation has beneficial electrophysiological effects on healthy hearts in the absence of autonomic imbalance
por: Lee, Steven W., et al.
Publicado: (2016)

Tackling Inflammation in Heart Failure With Preserved Ejection Fraction: Resurrection of Vagus Nerve Stimulation?
por: Kittipibul, Veraprapas, et al.
Publicado: (2022)

Chronic Low-Level Vagus Nerve Stimulation Improves Long-Term Survival in Salt-Sensitive Hypertensive Rats
por: Annoni, Elizabeth M., et al.
Publicado: (2019)

Intermittent electrical stimulation of the right cervical vagus nerve in salt-sensitive hypertensive rats: effects on blood pressure, arrhythmias, and ventricular electrophysiology
por: Annoni, Elizabeth M, et al.
Publicado: (2015)

Updates on Baroreflex Activation Therapy and Vagus Nerve Stimulation for Treatment of Heart Failure With Reduced Ejection Fraction
por: Babar, Natasha, et al.
Publicado: (2022)

Implantation of a vagus nerve stimulator for patients with heart failure with reduced ejection fraction: An educational video
por: Al Rameni, Dina, et al.
Publicado: (2022)

Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction
por: Jackson, Alice M, et al.
Publicado: (2021)

Differential Response to Interleukin‐1 Blockade With Anakinra on Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction Stratified According to Left Ventricular Ejection Fraction
por: Golino, Michele, et al.
Publicado: (2023)

Effects of Sacubitril/Valsartan on Serum Lipids in Heart Failure With Preserved Ejection Fraction
por: Selvaraj, Senthil, et al.
Publicado: (2021)

Cardiac Adrenergic Activation in Heart Failure With Preserved Ejection Fraction: A Role for β-Blockade?
por: Bristow, Michael R., et al.
Publicado: (2022)

Multilayer myocardial strain improves the diagnosis of heart failure with preserved ejection fraction
por: Tanacli, Radu, et al.
Publicado: (2020)

Cause of Death Among Patients With Diabetes and Heart Failure With Reduced Ejection Fraction
por: Sharma, Abhinav, et al.
Publicado: (2022)

The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction
por: Stahrenberg, Raoul, et al.
Publicado: (2010)

Renin–angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta‐analysis
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2017)

Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction
por: Nolte, Kathleen, et al.
Publicado: (2019)

Vagus nerve stimulation using a miniaturized wirelessly powered stimulator in pigs
por: Habibagahi, Iman, et al.
Publicado: (2022)

A combined cuff electrode array for organ-specific selective stimulation of vagus nerve enabled by Electrical Impedance Tomography
por: Ravagli, Enrico, et al.
Publicado: (2023)

Readmissions, Death and Its Associated Predictors in Heart Failure With Preserved Versus Reduced Ejection Fraction
por: Tay, Wan Ting, et al.
Publicado: (2021)

Patient‐reported outcomes in heart failure with preserved vs. reduced ejection fraction: focus on physical independence
por: Huang, Weiting, et al.
Publicado: (2020)

Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction
por: Edelmann, Frank, et al.
Publicado: (2011)

Clinical profile and one-year survival of patients with heart failure with reduced ejection fraction: The largest report from India
por: Chopra, Vijay K., et al.
Publicado: (2019)

Amount or intensity? Potential targets of exercise interventions in patients with heart failure with preserved ejection fraction
por: Bobenko, Anna, et al.
Publicado: (2017)

Advances in Our Clinical Understanding of Autonomic Regulation Therapy Using Vagal Nerve Stimulation in Patients Living With Heart Failure
por: Konstam, Marvin A., et al.
Publicado: (2022)

Case report on interaction of warfarin with herbal medicine “kadha”
por: Premchand, Rajendra Kumar, et al.
Publicado: (2021)

Outcome of angiotensin receptor-neprilysin inhibitor on anxiety and depression in heart failure with reduced ejection fraction vs. heart failure with preserved ejection fraction
por: Malik, Jahanzeb, et al.
Publicado: (2021)

Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction
por: Shen, Li, et al.
Publicado: (2019)

Pregnancy and delivery while receiving vagus nerve stimulation for the treatment of major depression: a case report
por: Husain, Mustafa M, et al.
Publicado: (2005)

Outcome assessment using estimation of left ventricular filling pressure in asymptomatic patients at risk for heart failure with preserved ejection fraction
por: Bobenko, Anna, et al.
Publicado: (2020)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
por: Liu, Dan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_anci3gu9dj24r77u6gvdiaruul